The -258A/G (SNP rs12885300) polymorphism of the human type 2 deiodinase gene is associated with a shift in the pattern of secretion of thyroid hormones following a TRH-induced acute rise in TSH

European Journal of Endocrinology

Volumn 166, Issue 5, 2012, Pages 839-845

  Peltsverger, Maya Y ^a,b   Butler, Peter W ^a,c   Alberobello, Anna Teresa ^a   Smith, Sheila ^a   Guevara, Yanina ^a   Dubaz, Ornella M ^a   Luzon, Javier A ^a   Linderman, Joyce ^a   Celi, Francesco S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; PROTIRELIN; THYROTROPIN; THYROXINE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIO2 GENE; ENDOCRINE FUNCTION TEST; FEMALE; GENE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HYPOPHYSIS THYROID SYSTEM; LIOTHYRONINE BLOOD LEVEL; LIOTHYRONINE SYNTHESIS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID HORMONE RELEASE; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL; TYPE 2 DEIODINASE GENE; UPREGULATION;

ADENINE NUCLEOTIDES; ADULT; COHORT STUDIES; FEMALE; GUANINE NUCLEOTIDES; HOMEOSTASIS; HUMANS; IODIDE PEROXIDASE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; YOUNG ADULT;

EID: 84862078915     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-1073     Document Type: Article

References (26)

1. Andersen S, Pedersen KM, Bruun NH & Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. Journal of Clinical Endocrinology and Metabolism 2002 87 1068-1072. (doi:10.1210/jc.87.3.1068)
2. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeold A & Bianco AC. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocrine Reviews 2008 29 898-938. (doi:10.1210/er.2008-0019)
3. 3 in euthyroid humans. Journal of Clinical Investigation 2005 115 2524-2533. (doi:10.1172/JCI25083)
4. Salvatore D, Tu H, Harney JW & Larsen PR. Type 2 iodothyronine deiodinase is highly expressed in human thyroid. Journal of Clinical Investigation 1996 98 962-968. (doi:10.1172/JCI118880)
5. Murakami M, Araki O, Hosoi Y, Kamiya Y, Morimura T, Ogiwara T, Mizuma H & Mori M. Expression and regulation of type II iodothyronine deiodinase in human thyroid gland. Endocrinology 2001 142 2961-2967. (doi:10.1210/en.142.7. 2961)
6. Brtko J, Bobalova J, Podoba J, Schmutzler C & Kohrle J. Thyroid hormone receptors and type I iodothyronine 5′-deiodinase activity of human thyroid toxic adenomas and benign cold nodules. Experimental and Clinical Endocrinology & Diabetes 2002 110 166-170. (doi:10.1055/s-2002-32147)
7. Celi FS, Coppotelli G, Chidakel A, Kelly M, Brillante BA, Shawker T, Cherman N, Feuillan PP & Collins MT. The role of type 1 and type 2 5′-deiodinase in the pathophysiology of the 3,5,3′-triiodothyronine toxicosis of McCune-Albright syndrome. Journal of Clinical Endocrinology and Metabolism 2008 93 2383-2389. (doi:10.1210/jc.2007-2237)
8. Canettieri G, Celi FS, Baccheschi G, Salvatori L, Andreoli M & Centanni M. Isolation of human type 2 deiodinase gene promoter and characterization of a functional cyclic adenosine monophosphate response element. Endocrinology 2000 141 1804-1813. (doi:10.1210/en.141.5.1804)
9. Bartha T, Kim SW, Salvatore D, Gereben B, Tu HM, Harney JW, Rudas P & Larsen PR. Characterization of the 5′-flanking and 50-untranslated regions of the cyclic adenosine 3′,5′-monophosphate- responsive human type 2 iodothyronine deiodinase gene. Endocrinology 2000 141 229-237. (doi:10.1210/en.141.1.229)
10. Butler PW, Smith SM, Linderman JD, Brychta RJ, Alberobello AT, Dubaz OM, Luzon JA, Skarulis MC, Cochran CS, Wesley RA, Pucino F & Celi FS. The Thr92Ala 5′ type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormon-estimulation test: a pharmacogenomic study. Thyroid 2010 20 1407-1412. (doi:10.1089/thy.2010.0244)
11. Peeters RP, van den Beld AW, Attalki H, Toor H, de Rijke YB, Kuiper GG, Lamberts SW, Janssen JA, Uitterlinden AG & Visser TJ. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. American Journal of Physiology. Endocrinology and Metabolism 2005 289 E75-E81. (doi:10.1152/ajpendo.00571.2004)
12. He B, Li J, Wang G, Ju W, Lu Y, Shi Y, He L & Zhong N. Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2009 33 986-990. (doi:10.1016/j.pnpbp.2009.05.003)
13. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TI, Poehlman ET, Shuldiner AR & Celi FS. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes 2002 51 880-883. (doi:10.2337/diabetes.51.3.880)
14. 2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. Journal of Clinical Endocrinology and Metabolism 1994 79 152-159. (doi:10.1210/jc.79.1.152)
15. Laurberg P. Mechanisms governing the relative proportions of thyroxine and 3,5,3′-triiodothyronine in thyroid secretion. Metabolism 1984 33 379-392. (doi:10.1016/0026-0495(84)90203-8)
16. Jakobs TC, Schmutzler C, Meissner J & Kohrle J. The promoter of the human type I 50-deiodinase gene - mapping of the transcription start site and identification of a DRC4 thyroid-hormone- responsive element. European Journal of Biochemistry 1997 247 288-297. (doi:10.1111/j.1432-1033.1997.00288.x)
17. Dora JM, Machado WE, Rheinheimer J, Crispim D & Maia AL. Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis. European Journal of Endocrinology 2010 163 427-434. (doi:10.1530/EJE-10-0419)
18. Meulenbelt I, Min JL, Bos S, Riyazi N, Houwing-Duistermaat JJ, van der Wijk HJ, Kroon HM, Nakajima M, Ikegawa S, Uitterlinden AG, van Meurs JB, van der Deure WM, Visser TJ, Seymour AB, Lakenberg N, van der Breggen R, Kremer D, van Duijn CM, Kloppenburg M, Loughlin J & Slagboom PE. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Human Molecular Genetics 2008 17 1867-1875. (doi:10.1093/hmg/ddn082)
19. Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM & Dayan CM. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. Journal of Clinical Endocrinology and Metabolism 2009 94 1623-1629. (doi:10.1210/jc.2008-1301)
20. Torlontano M, Durante C, Torrente I, Crocetti U, Augello G, Ronga G, Montesano T, Travascio L, Verrienti A, Bruno R, Santini S, D'Arcangelo P, Dallapiccola B, Filetti S & Trischitta V. Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. Journal of Clinical Endocrinology and Metabolism 2008 93 910-913. (doi:10.1210/jc.2007-1067)
21. Grarup N, Andersen MK, Andreasen CH, Albrechtsen A, Borch- Johnsen K, Jorgensen T, Auwerx J, Schmitz O, Hansen T & Pedersen O. Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 363-366. (doi:10.1210/jc.2006-1958)
22. de Jong FJ, Peeters RP, den Heijer T, van der Deure WM, Hofman A, Uitterlinden AG, Visser TJ & Breteler MM. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. Journal of Clinical Endocrinology and Metabolism 2007 92 636-640. (doi:10.1210/jc.2006-1331)
23. Canani LH, Capp C, Dora JM, Meyer EL, Wagner MS, Harney JW, Larsen PR, Gross JL, Bianco AC & Maia AL. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2005 90 3472-3478. (doi:10.1210/jc.2004- 1977)
24. Coppotelli G, Summers A, Chidakel A, Ross JM & Celi FS. Functional characterization of the 258 A/G (D2-ORFa-Gly3Asp) human type-2 deiodinase polymorphism: a naturally occurring variant increases the enzymatic activity by removing a putative repressor site in the 5′ UTR of the gene. Thyroid 2006 16 625-632. (doi:10.1089/thy.2006.16.625)
25. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG & Visser TJ. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 2880-2888. (doi:10.1210/jc.2002-021592)
26. Faglia G. The clinical impact of the thyrotropin-releasing hormone test. Thyroid 1998 8 903-908. (doi:10.1089/thy.1998.8.903)